Technology

Anthropic launches Claude Science for researchers, labs and biotech teams

Anthropic pushed Claude into the lab with a workbench that ties PubMed, Jupyter and compute into one traceable workspace.

Marcus Williams··1 min read
Published
Listen to this article0:00 min
Anthropic launches Claude Science for researchers, labs and biotech teams
Source: Yahoo Tech

Anthropic on Tuesday released Claude Science, an AI workbench built for scientists that folds literature review, data analysis, visualization and manuscript preparation into a single interface. Claude Science is meant to cut down the time researchers spend bouncing between databases, pipelines and software while keeping results tied back to source code and environment for reproducibility.

Claude Science is in beta for Claude Pro, Max, Team and Enterprise users, and it can run locally on macOS or Linux or remotely over SSH or an HPC login node. The app ships with more than 60 curated skills and connectors for genomics, single-cell analysis, proteomics, structural biology and cheminformatics, and it can render 3D protein structures, genome browser tracks and chemical drawings inside the workspace. A reviewer agent checks citations and calculations, flagging and correcting errors, while each figure carries the exact code and environment used to generate it, plus a plain-language description and full message history.

AI-generated illustration
AI-generated illustration

Claude Science extends a life sciences push Anthropic began last fall with Claude for Life Sciences, then widened in January to healthcare tools and additional support for clinical trial management and regulatory operations. In October 2025, Anthropic added connectors to systems including Benchling, BioRender, PubMed, Scholar Gateway, Synapse.org and 10x Genomics, and in February it named the Allen Institute and Howard Hughes Medical Institute as founding partners in life sciences.

Related photo
Source: anthropic.com

In May, Anthropic formed a $200 million partnership with the Gates Foundation over four years, backing global health, life sciences, education and economic mobility programs, including work on vaccines, therapies, public-health data and neglected diseases such as polio, HPV and eclampsia/preeclampsia.

This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.

Did this article answer your question?

Discussion

More in Technology